MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+18.74%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$845M
AUM Growth
+$845M
(+49%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
27.01%
Top 10 Holdings %
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19
Top Buys
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
American Healthcare REIT
AHR
|
$9.88M |
| 5 |
ODDITY Tech
ODD
|
$8.91M |
Top Sells
| 1 |
PG&E
PCG
|
$4.69M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.27M |
| 3 |
Structure Therapeutics
GPCR
|
$4.16M |
| 4 |
argenx
ARGX
|
$3.8M |
| 5 |
Las Vegas Sands
LVS
|
$3.69M |
Sector Composition
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 5.62% |
| 3 | Technology | 5.05% |
| 4 | Consumer Discretionary | 2.94% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dutch Bros
BROS
$9.12B
| $1.65M | 0.2% | +50,000 | New | +$1.65M |
|
77
Dynatrace
DT
$15.3B
| $1.63M | 0.19% | +35,000 | New | +$1.63M |
|
78
Morgan Stanley Direct Lending Fund
MSDL
$1.57B
| $1.56M | 0.18% | +72,212 | New | +$1.56M |
|
79
Olema Pharmaceuticals
OLMA
$375M
| $1.53M | 0.18% | +135,000 | New | +$1.53M |
|
80
Porch Group
PRCH
$1.77B
| $1.51M | 0.18% | +350,000 | New | +$1.51M |
|
81
MeridianLink
MLNK
$1.47B
| $1.5M | 0.18% | +80,000 | New | +$1.5M |
|
82
Mersana Therapeutics
MRSN
$36.5M
| $1.39M | 0.16% | +310,000 | New | +$1.39M |
|
83
Unicycive Therapeutics
UNCY
$74M
| $1.38M | 0.16% | +1,000,000 | New | +$1.38M |
|
84
PepGen
PEPG
$38M
| $1.26M | 0.15% | +85,886 | New | +$1.26M |
|
85
Praxis Precision Medicines
PRAX
$958M
| $1.22M | 0.14% | +20,000 | New | +$1.22M |
|
86
Cardlytics
CDLX
$54.3M
| $1.09M | 0.13% | +75,000 | New | +$1.09M |
|
87
Compass Therapeutics
CMPX
$483M
| $990K | 0.12% | 500,000 | – | – |
|
88
Stoke Therapeutics
STOK
$1.08B
| $912K | 0.11% | +67,584 | New | +$912K |
|
89
NVIDIA
NVDA
$4.24T
| $904K | 0.11% | +1,000 | New | +$904K |
|
90
Milestone Pharmaceuticals
MIST
$156M
| $895K | 0.11% | +500,000 | New | +$895K |
|
91
Bowman Consulting
BWMN
$737M
| $870K | 0.1% | +25,000 | New | +$870K |
|
92
Runway Growth Finance
RWAY
$394M
| $848K | 0.1% | 70,000 -21,739 | -24% | -$263K |
|
93
Stevanato
STVN
$6.28B
| $642K | 0.08% | +20,000 | New | +$642K |
|
94
SoFi Technologies
SOFI
$30.6B
| $584K | 0.07% | +80,000 | New | +$584K |
|
95
Five Star Bancorp
FSBC
$700M
| $563K | 0.07% | +25,000 | New | +$563K |
|
|
BOLD
96
Boundless Bio
BOLD
$25.1M
| $445K | 0.05% | +31,250 | New | +$445K |
|
97
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $344K | 0.04% | +31,189 | New | +$344K |
|
98
Cidara Therapeutics
CDTX
$1.66B
| $340K | 0.04% | 369,099 | – | – |
|
99
Keurig Dr Pepper
KDP
$39.5B
| $307K | 0.04% | +10,000 | New | +$307K |
|
|
MTEM
100
DELISTED
Molecular Templates, Inc.
MTEM
| $236K | 0.03% | 105,493 -16,348 | -13% | -$36.6K |
|